Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v5-EN
Language French English
Date Updated 2024-10-31 2024-07-04
Drug Identification Number 02453061 02453061
Brand name APO-PERINDOPRIL-INDAPAMIDE APO-PERINDOPRIL-INDAPAMIDE
Common or Proper name PERINDOPRIL-INDAPAMIDE PERINDOPRIL-INDAPAMIDE
Company Name APOTEX INC APOTEX INC
Ingredients PERINDOPRIL ERBUMINE INDAPAMIDE PERINDOPRIL ERBUMINE INDAPAMIDE
Strength(s) 8MG 2.5MG 8MG 2.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C09BA C09BA
ATC description ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-18 2024-06-18
Estimated end date 2024-12-13 2024-07-26
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments 30 BLS available
Health Canada comments